Financial Performance - The company's operating revenue for the first half of 2021 was ¥81,706,711.20, representing a 105.28% increase compared to ¥39,803,417.76 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was -¥11,218,631.70, compared to -¥5,910,404.59 in the previous year, indicating a continued loss[18]. - The net cash flow from operating activities was ¥7,246,190.71, a significant improvement from -¥46,889,813.19 in the same period last year[18]. - Operating revenue for the current period reached ¥81,706,711.20, a 105.28% increase compared to ¥39,803,417.76 in the previous period[35]. - Operating costs increased by 82.33% to ¥68,295,384.30 from ¥37,457,015.50 year-on-year[35]. - The company reported a net loss of ¥14,055,603.75 for the first half of 2021, compared to a net loss of ¥5,735,311.12 in the first half of 2020, representing a deterioration in performance[106]. - The loss attributable to shareholders of the parent company was ¥11,218,631.70, compared to a loss of ¥5,910,404.59 in the previous year[106]. - The total comprehensive loss for the first half of 2021 was ¥13,682,685.31, compared to a loss of ¥5,813,129.98 in the same period of 2020[106]. Assets and Liabilities - The total assets decreased by 4.34% to ¥3,189,841,376.02 from ¥3,334,571,091.58 at the end of the previous year[19]. - The total liabilities decreased from ¥2,061,673,621.86 to ¥1,930,606,600.06, a reduction of about 6.36%[98]. - Current liabilities decreased from ¥1,142,424,397.74 to ¥861,497,352.24, a decrease of approximately 24.6%[98]. - Non-current liabilities increased from ¥919,249,224.12 to ¥1,069,109,247.82, an increase of about 16.3%[98]. - Total equity decreased from ¥1,272,897,469.72 to ¥1,259,234,775.96, a decline of approximately 1.08%[99]. - The company's cash and cash equivalents as of June 30, 2021, amount to ¥183,492,737.95, a decrease from ¥207,225,771.03 at the end of 2020[96]. - Total current assets decreased from ¥719,321,307.10 at the end of 2020 to ¥359,280,354.44 as of June 30, 2021[96]. Research and Development - Research and development expenses surged by 413.35% to ¥2,447,915.54 from ¥476,848.80 in the previous period[35]. - The company achieved investment income of ¥9,736,246.35, up 73.5% from ¥5,599,093.51 in the same period last year[105]. Environmental Responsibility - The company invested nearly 400 million yuan in environmental protection facilities to comply with national regulations[54]. - The company has implemented various pollution control systems, including a biological fermentation tail gas treatment system and a wastewater treatment system[56]. - The company has established an emergency response plan for environmental incidents and conducts regular training for employees[59]. - The company has committed to fulfilling the obligations of the equity acquisition agreement and will pay the performance deposit and acquisition price in full as stipulated[65]. Shareholder Information - The total number of common shareholders as of the end of the reporting period is 27,319[87]. - The largest shareholder, Shanghai Zhongneng Enterprise Development (Group) Co., Ltd., holds 200,000,000 shares, representing 29.20% of the total shares[88]. - The company has not issued any preferred shares or convertible bonds during the reporting period[94]. Legal Matters - The company is involved in a significant lawsuit where it claims ¥157 million in compensation due to unfulfilled performance commitments from a previous agreement[72]. - The company has ongoing litigation related to a loan arbitration case, with a claim for repayment of ¥91.8 million plus interest at an annual rate of 5.0025%[75]. - The company has faced a total of ¥189.60 million in legal fees related to arbitration proceedings[75]. Corporate Governance - The company has committed to not engaging in competitive business activities with its main business, ensuring compliance with relevant laws and regulations[62]. - The company guarantees not to harm the interests of minority shareholders in its normal production and operational activities[62]. - The company has taken measures to prevent illegal occupation of funds and assets belonging to its main business[63]. Financial Reporting and Accounting - The company adheres to the accounting standards for listed companies, ensuring that financial statements accurately reflect its financial status and operational results[142]. - The company recognizes the operating results and cash flows of subsidiaries from the date control is obtained, adjusting the financial statements based on the fair value of identifiable assets and liabilities at the acquisition date[149]. - The company assesses expected credit losses based on historical loss experience and forward-looking information, applying a simplified approach for receivables without significant financing components[162].
宁科生物(600165) - 2021 Q2 - 季度财报